Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Bausch Health — Bausch & Lomb

Tracked across 6 events · 37 articles · First seen Jun 18, 2026 · Last active Sep 11, 2026

Sentiment
12
Attention
4
Events
6
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 30
Business
Impact: Bausch + Lomb Corporation announced new findings from its third annual State of Dry Eye survey, highlighting the emotional impact of dry eye and the benefits of prescription treatments, which could positively influence its product sales and market position.
Jul 01, 2026 · 6 articles
2 20
Tech
Impact: Bausch Health — Bausch & Lomb is the creator and owner of the Orphia platform, which expands its offerings beyond traditional products into digital health, potentially improving its market position.
Jul 09, 2026 · 6 articles
2 15
Regulatory
Bausch Health — Bausch & Lomb Corporation announced that the European Union granted CE Mark approval for SeeLyra, its next-generation femtosecond laser platform. SeeLyra is designed to provide surgeons with enhanced precision and control in…
Impact: Bausch Health — Bausch & Lomb received CE Mark approval for its next-generation SeeLyra femtosecond laser, expanding its European surgical device portfolio. The approval is a positive but incremental development for the company's premium cataract and refractive surgery business.
Sep 11, 2026 · 6 articles
4 0
Regulatory
Impact: Bausch Health — Bausch & Lomb is the licensee for NicOx's first product VYZULTA, but is not directly involved in the NCX 470 NDA submission.
Aug 10, 2026 · 6 articles
2 5
Business
Impact: Bausch Health — Bausch & Lomb holds exclusive worldwide license for VYZULTA, a commercial product generating revenue for NicOx. This provides ongoing cash flow but is not the focus of the announcement.
Sep 02, 2026 · 6 articles
4 0
Business
Impact: Bausch + Lomb is the exclusive worldwide licensee for NicOx's first product, VYZULTA.
Jun 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Bausch Health — Bausch & Lomb live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.